Literature DB >> 911654

A comparative review of the pharmacology of nomifensine.

I Hoffmann.   

Abstract

1. Nomifensine is a new substance which showed, in tests for antidepressant activity, a pronounced effect which is quantitatively better than that of the reference substances. 2. With regard to thymoleptic effects in animal studies the effect of nomifensine is similar to that of tricyclic antidepressants, but nomifensine has no pronounced anticholinergic activity. 3. Nomifensine influences the cardiovascular system very slightly. 4. The mechanism of action of nomifensine differs from that of tricyclic antidepressants and must be clearly differentiated from phenylalkyl amines with sympathomimetric activity. 5. Nomifensine is a compound with a special, new profile of action, and thus cannot be calssified in known categories.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 911654      PMCID: PMC1429114          DOI: 10.1111/j.1365-2125.1977.tb05762.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  The 6-hydroxydopamine rotational model for the detection of dopamine agonist activity: reliability of effect from different locations of 6-hydroxydopamine.

Authors:  B Costall; R J Naylor; C Pycock
Journal:  J Pharm Pharmacol       Date:  1975-12       Impact factor: 3.765

2.  Actions of dopaminergic agonists on motor function.

Authors:  B Costall; R J Naylor
Journal:  Adv Neurol       Date:  1975

3.  Effect of nomifensine on motor activity, dopamine turnover rate and cyclic 3',5;-adenosine monophosphate concentrations of rat striatum.

Authors:  H J Gerhards; A Carenzi; E Costa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

4.  8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline, a new antidepressant.

Authors:  I Hoffmann
Journal:  Arzneimittelforschung       Date:  1973-01

5.  [8-amino-4-phenyl-1,2,3,4-tetrahydroisoquinolines, a new group of antidepressive psycholeptic drugs].

Authors:  I Hoffmann; G Ehrhart; K Schmitt
Journal:  Arzneimittelforschung       Date:  1971-07

6.  A comparison of circling models for the detection of antiparkinson activity.

Authors:  B Costall; R J Naylor
Journal:  Psychopharmacologia       Date:  1975

7.  Nomifensine: a potent dopaminergic agonist of antiparkinson potential.

Authors:  B Costall; D M Kelly; R J Naylor
Journal:  Psychopharmacologia       Date:  1975

8.  [Proceedings: On the central action of nomifensine (author's transl)].

Authors:  J Maj; Z Kapturkiewicz; J Michaluk
Journal:  Arzneimittelforschung       Date:  1976
  8 in total
  8 in total

1.  Assessment of the anticholinergic effects of antidepressants in a single-dose cross-over study of salivation and plasma levels.

Authors:  L Clemmesen; P L Mikkelsen; H Lund; T G Bolwig; O J Rafaelsen
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

2.  Interaction of alcohol with maprotiline or nomifensine: echocardiographic and psychometric effects.

Authors:  C Strömberg; A Suokas; T Seppälä
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 3.  Catecholamines: role in health and disease.

Authors:  R Laverty
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

4.  A comparison of the pharmacodynamic profiles of nomifensine and amitriptyline in normal subjects.

Authors:  M Y Chan; R Ehsanullah; J Wadsworth; J McEwen
Journal:  Br J Clin Pharmacol       Date:  1980-03       Impact factor: 4.335

5.  Effects of acute and chronic treatment with an atypical antidepressant drug, nomifensine, on the sleep-wake activity in rats.

Authors:  Z Lelkes; F Obál; G Benedek; G Rubicsek; P Alföldi; F Obál
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-02       Impact factor: 3.000

Review 6.  Rapid eye movement sleep and sleep continuity. Depression and antidepressants.

Authors:  A N Nicholson; P A Pascoe
Journal:  Drugs       Date:  1989       Impact factor: 9.546

7.  Nomifensine: A review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-07       Impact factor: 9.546

8.  Attenuated response to nomifensine in rats during a swim test following lesion of the habenula complex.

Authors:  E W Thornton; J A Evans; C Harris
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.